Real Scientific Canada™ Launches CBD Hemp Oil Nationwide
Vancouver, BC – October 4, 2018 – Real Scientific Canada™, a brand founded on the importance of spreading cannabis health education, has today announced the launch of its cannabis products across Canada through Canadian extraction and formulation company Salvation Botanicals, Ltd. (“Salvation”).
On October 17, Real Scientific Canada™ will be introducing several of its cannabis products, including its globally-recognized Real Scientific Hemp Oil™ (RSHO™) line. This product line was the first CBD product line in the U.S. to be sold over state lines and the first to receive import permits in Paraguay, Mexico and Brazil, and will now be available for Canadian consumers.
“This an incredible time for the Canadian cannabis industry and we are pleased to be making our mark on such a historic milestone by introducing a brand known for its portfolio of achievements in the industry,” said Kenneth Smith, President of Real Scientific Canada™. “Real Scientific Canada is a pioneer in this emerging legal industry and we’re thrilled to be launching products that are designed to help meet a variety of needs of the Canadian consumer.”
Real Scientific Hemp Oil™ is a hemp-derived cannabidiol (CBD) product line that helps consumers without the intoxicating effects of THC. The products come in several different formulations including RSHO™ Gold Label, which is refined to provide the maximum possible concentration of CBD; RSHO™ Blue Label, which features the cannabis plant’s full spectrum of minor cannabinoids, terpenes, natural chlorophyll for additional essential vitamins and minerals; and RSHO™ Green Label, a raw formulation which is the closest of all three RSHO™ types to the organic makeup of the natural hemp plant, providing unadulterated phytocannabinoids, including a high concentration of CBDa.
Salvation Botanicals, the manufacturer of Real Scientific Canada™, was founded on a commitment to the science of standardization and consumer protection through analytical testing and the development of stringent production processes. Salvation has developed high-volume production methods based on their understanding of high-quality, standardized cannabinoid products.
“This is an exciting partnership for both companies as we enter into a new era for the Canadian cannabis industry,” said Rob McIntyre, Chief Financial Officer of Salvation Botanicals. “Real Scientific is a brand grown from new and creative ideas and we look forward to working with them as they continue to explore new territories in the cannabis sector.”
About Real Scientific Canada™
A brand with a rich history backed by science, Real Scientific Canada™ aims to help customers feel their best with our innovative lines of cannabis products. The company has become global pioneers in the industry by receiving the first import permits for its Real Scientific Hemp Oil™ products in Paraguay, Mexico and Brazil. To learn more, please visit http://realscientific.ca/.
About Salvation Botanicals, Ltd.
Salvation Botanicals is a private company based in Vancouver Island, British Columbia, that is dedicated to the testing and production of high quality standardized cannabinoid products for the international cannabis market. Salvation operates one of the first analytics laboratories in Canada, accredited by Health Canada to test cannabis and derivatives.
Salvation Botanicals holds a Dealer’s License under the Controlled Substances Act, with authority to extract and produce oil within Health Canada guidelines. In 2016 Health Canada granted Salvation a Hemp Processing License (HPL) permitting production and sale and export of seed & grain and its derivatives.
This press release may contain certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is subject to the Safe Harbor created by those sections. This material contains statements about expected future events and/or financial results that are forward-looking in nature and subject to risks and uncertainties. Such forward-looking statements by definition involve risks, uncertainties and other factors, which may cause the actual results, performance or achievements of Medical Marijuana, Inc. to be materially different from the statements made herein.
CAUTIONARY STATEMENT REGARDING FORWARD-LOOKING INFORMATION: This news release includes certain “forward-looking statements” under applicable Canadian securities legislation. Forward-looking statements include, but are not limited to, statements with respect to: the terms and conditions of the proposed transaction; the terms and conditions of the proposed private placement; use of funds; and the business and operations of the Company after the proposed change of business. Forward-looking statements are necessarily based upon a number of estimates and assumptions that, while considered reasonable, are subject to known and unknown risks, uncertainties, and other factors which may cause the actual results and future events to differ materially from those expressed or implied by such forward-looking statements. Such factors include, but are not limited to: general business, economic, competitive, political and social uncertainties; delay or failure to receive board, shareholder or regulatory approvals; and the uncertainties surrounding the cannabis industry in North America. There can be no assurance that such statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on forward-looking statements. Salvation disclaims any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law.
FOOD AND DRUG ADMINISTRATION (FDA) DISCLOSURE
These statements have not been evaluated by the FDA and are not intended to diagnose, treat or cure any disease.
Medical Marijuana, Inc. does not sell or distribute any products that are in violation of the United States Controlled Substances Act (US.CSA). These companies do grow, sell, and distribute hemp-based products and are involved with the federally legal distribution of medical marijuana-based products within certain international markets. Cannabidiol is a natural constituent of hemp oil.
Public Relations Contact:
Chief Executive Officer